Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Grissmer

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 21, 2004
A novel non-neuronal hSK3 isoform with a dominant-negative effect on hSK3 currentsOliver H Wittekindt, Tobias Dreker, Deborah J Morris-Rosendahl, et al.
The European Journal of Neuroscience|December 3, 2008
AQP4 expression in striatal primary cultures is regulated by dopamine--implications for proliferation of astrocytesEva Küppers, Corinna Gleiser, Veronica Brito, et al.
The Journal of Biological Chemistry|July 23, 2002
Structure of the BgK-Kv1.1 complex based on distance restraints identified by double mutant cycles. Molecular basis for convergent evolution of Kv1 channel blockersBernard Gilquin, Judith Racapé, Anja Wrisch, et al.
Journal of Neurochemistry|October 13, 2006
Selective blockage of Kv1.3 and Kv3.1 channels increases neural progenitor cell proliferationStefan Liebau, Christian Pröpper, Tobias Böckers, et al.
Pharmacological Reviews|March 8, 2017
International Union of Basic and Clinical Pharmacology. C. Nomenclature and Properties of Calcium-Activated and Sodium-Activated Potassium ChannelsLeonard K Kaczmarek, Richard W Aldrich, K George Chandy, et al.
Molecular Pharmacology|May 25, 2004
Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulatorsJulia Vennekamp, Heike Wulff, Christine Beeton, et al.
Protein Science : a Publication of the Protein Society|November 29, 2007
Chemical synthesis and 1H-NMR 3D structure determination of AgTx2-MTX chimera, a new potential blocker for Kv1.2 channel, derived from MTX and AgTx2 scorpion toxinsCyril Pimentel, Sarrah M'Barek, Violetta Visan, et al.
Journal of Neurochemistry|April 27, 2007
Formation of cellular projections in neural progenitor cells depends on SK3 channel activityStefan Liebau, Bianca Vaida, Christian Proepper, et al.
Journal of Neurochemistry|July 16, 2008
Identification and characterization of a novel, shorter isoform of the small conductance Ca2+ -activated K+ channel SK2Saravana R K Murthy, Georgeta Teodorescu, Ingrid M Nijholt, et al.
The Biochemical Journal|September 10, 2003
The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channelsStéphanie Mouhat, Amor Mosbah, Violeta Visan, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 21, 2004
A novel non-neuronal hSK3 isoform with a dominant-negative effect on hSK3 currentsOliver H Wittekindt, Tobias Dreker, Deborah J Morris-Rosendahl, et al.
The European Journal of Neuroscience|December 3, 2008
AQP4 expression in striatal primary cultures is regulated by dopamine--implications for proliferation of astrocytesEva Küppers, Corinna Gleiser, Veronica Brito, et al.
The Journal of Biological Chemistry|July 23, 2002
Structure of the BgK-Kv1.1 complex based on distance restraints identified by double mutant cycles. Molecular basis for convergent evolution of Kv1 channel blockersBernard Gilquin, Judith Racapé, Anja Wrisch, et al.
Journal of Neurochemistry|October 13, 2006
Selective blockage of Kv1.3 and Kv3.1 channels increases neural progenitor cell proliferationStefan Liebau, Christian Pröpper, Tobias Böckers, et al.
Pharmacological Reviews|March 8, 2017
International Union of Basic and Clinical Pharmacology. C. Nomenclature and Properties of Calcium-Activated and Sodium-Activated Potassium ChannelsLeonard K Kaczmarek, Richard W Aldrich, K George Chandy, et al.
Molecular Pharmacology|May 25, 2004
Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulatorsJulia Vennekamp, Heike Wulff, Christine Beeton, et al.
Protein Science : a Publication of the Protein Society|November 29, 2007
Chemical synthesis and 1H-NMR 3D structure determination of AgTx2-MTX chimera, a new potential blocker for Kv1.2 channel, derived from MTX and AgTx2 scorpion toxinsCyril Pimentel, Sarrah M'Barek, Violetta Visan, et al.
Journal of Neurochemistry|April 27, 2007
Formation of cellular projections in neural progenitor cells depends on SK3 channel activityStefan Liebau, Bianca Vaida, Christian Proepper, et al.
Journal of Neurochemistry|July 16, 2008
Identification and characterization of a novel, shorter isoform of the small conductance Ca2+ -activated K+ channel SK2Saravana R K Murthy, Georgeta Teodorescu, Ingrid M Nijholt, et al.
The Biochemical Journal|September 10, 2003
The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channelsStéphanie Mouhat, Amor Mosbah, Violeta Visan, et al.
Pageof 5